Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of HEALTHCARE GLOBAL ENTER.. For more details, see the HEALTHCARE GLOBAL ENTER. quarterly results and HEALTHCARE GLOBAL ENTER. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.8 |
No. of shares | m | 139.29 |
1 Week | % | -1.8 |
1 Month | % | 7.2 |
1 Year | % | 38.5 |
52 week H/L | Rs | 401.0/257.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
HEALTHCARE GLOBAL ENTER. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 335 | 249 | 193 | 285 | 320 | |
Low | Rs | 179 | 67 | 63 | 159 | 249 | |
Sales per share (Unadj.) | Rs | 111.0 | 123.2 | 80.5 | 100.3 | 121.6 | |
Earnings per share (Unadj.) | Rs | -3.5 | -14.1 | -17.6 | 2.8 | 1.3 | |
Diluted earnings per share | Rs | -2.2 | -9.0 | -15.9 | 2.8 | 1.3 | |
Cash flow per share (Unadj.) | Rs | 6.2 | 2.6 | -4.9 | 14.2 | 13.0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 53.6 | 42.2 | 51.6 | 62.1 | 61.0 | |
Adj. book value per share | Rs | 33.8 | 26.9 | 46.4 | 62.0 | 60.9 | |
Shares outstanding (eoy) | m | 87.92 | 88.69 | 125.36 | 139.01 | 139.12 | |
Price / Sales ratio | x | 2.3 | 1.3 | 1.6 | 2.2 | 2.3 | |
Avg P/E ratio | x | -73.2 | -11.1 | -7.3 | 79.3 | 224.5 | |
P/CF ratio (eoy) | x | 41.7 | 60.8 | -25.9 | 15.7 | 21.9 | |
Price / Book Value ratio | x | 4.8 | 3.7 | 2.5 | 3.6 | 4.7 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 22,593 | 13,982 | 16,055 | 30,878 | 39,585 | |
Total wages/salary | Rs m | 1,845 | 2,080 | 1,959 | 2,336 | 2,751 |
HEALTHCARE GLOBAL ENTER. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 9,760 | 10,923 | 10,092 | 13,948 | 16,914 | |
Other income | Rs m | 101 | 103 | 212 | 157 | 316 | |
Total revenues | Rs m | 9,861 | 11,026 | 10,304 | 14,105 | 17,230 | |
Gross profit | Rs m | 1,116 | 1,566 | 285 | 3,281 | 2,802 | |
Depreciation | Rs m | 851 | 1,484 | 1,592 | 1,583 | 1,635 | |
Interest | Rs m | 699 | 1,376 | 1,192 | 978 | 1,035 | |
Profit before tax | Rs m | -334 | -1,193 | -2,287 | 878 | 449 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -25 | 62 | -76 | 488 | 273 | |
Profit after tax | Rs m | -309 | -1,255 | -2,211 | 389 | 176 | |
Gross profit margin | % | 11.4 | 14.3 | 2.8 | 23.5 | 16.6 | |
Effective tax rate | % | 7.5 | -5.2 | 3.3 | 55.7 | 60.7 | |
Net profit margin | % | -3.2 | -11.5 | -21.9 | 2.8 | 1.0 |
HEALTHCARE GLOBAL ENTER. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,730 | 3,038 | 4,350 | 5,023 | 5,803 | |
Current liabilities | Rs m | 5,473 | 5,757 | 4,652 | 4,697 | 5,703 | |
Net working cap to sales | % | -28.1 | -24.9 | -3.0 | 2.3 | 0.6 | |
Current ratio | x | 0.5 | 0.5 | 0.9 | 1.1 | 1.0 | |
Inventory Days | Days | 86 | 77 | 56 | 37 | 34 | |
Debtors Days | Days | 59 | 62 | 67 | 57 | 65 | |
Net fixed assets | Rs m | 13,537 | 19,232 | 15,663 | 17,112 | 17,304 | |
Share capital | Rs m | 879 | 887 | 1,254 | 1,390 | 1,391 | |
"Free" reserves | Rs m | 3,832 | 2,855 | 5,211 | 7,246 | 7,094 | |
Net worth | Rs m | 4,711 | 3,742 | 6,465 | 8,636 | 8,485 | |
Long term debt | Rs m | 5,169 | 5,296 | 3,462 | 3,629 | 3,617 | |
Total assets | Rs m | 16,267 | 22,270 | 20,013 | 22,136 | 23,107 | |
Interest coverage | x | 0.5 | 0.1 | -0.9 | 1.9 | 1.4 | |
Debt to equity ratio | x | 1.1 | 1.4 | 0.5 | 0.4 | 0.4 | |
Sales to assets ratio | x | 0.6 | 0.5 | 0.5 | 0.6 | 0.7 | |
Return on assets | % | 2.4 | 0.5 | -5.1 | 6.2 | 5.2 | |
Return on equity | % | -6.6 | -33.5 | -34.2 | 4.5 | 2.1 | |
Return on capital | % | 3.7 | 2.0 | -11.0 | 15.1 | 12.3 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 3.0 | 3.8 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 296 | 414 | 0 | 0 | 0 | |
Fx inflow | Rs m | 344 | 404 | 196 | 218 | 490 | |
Fx outflow | Rs m | 345 | 470 | 19 | 69 | 44 | |
Net fx | Rs m | -1 | -67 | 177 | 149 | 446 |
HEALTHCARE GLOBAL ENTER. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 985 | 1,301 | 1,205 | 2,201 | 2,516 | |
From Investments | Rs m | -2,382 | -1,014 | -1,711 | 1,246 | -1,330 | |
From Financial Activity | Rs m | 835 | -584 | 1,122 | -1,549 | -1,401 | |
Net Cashflow | Rs m | -562 | -297 | 617 | 1,898 | -215 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: B S Ajai Kumar | COMP SEC: Sunu Manuel | YEAR OF INC: 1998 | BSE CODE: 539787 | FV (Rs): 10 | DIV YIELD (%): - |
Read: HEALTHCARE GLOBAL ENTER. 2022-23 Annual Report Analysis
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare HEALTHCARE GLOBAL ENTER. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.